DLQI as a major criterion for introduction of systemic agents in patients with mild psoriasis.

BACKGROUND Psoriasis is a skin inflammatory chronic disease with negative physical, psychological and social repercussions for those affected. However, patients suffering from mild disease also complain about negative impact on their quality of life, making it difficult for physicians to choose the best treatment strategy. OBJECTIVES Understanding the… CONTINUE READING